What did @joeknowsthings2 actually say?
The creator laid out a specific GHK-Cu dosing protocol: daily use works best because of the peptide's short half-life, "a few hours," which clears it quickly. They recommended "one and a half to 2 mg per day every day for six to eight weeks," followed by a four-week break. Alternate schedules like every other day or five days on, two days off were mentioned as cost-saving options that still work but produce "slower and less pronounced" results. The central argument is that consistency drives collagen production, and daily dosing maximizes skin and tissue repair benefits.
The framing is confident and protocol-specific, the kind of content that reads as clinical advice even when it isn't. That's worth keeping in mind as we get into what the research actually says.
Does the science back this up?
Partially, and with significant caveats. The half-life claim has some biological basis, but the dosing protocol is essentially extrapolated from animal and in vitro data, not human clinical trials.
GHK-Cu (glycyl-L-histidyl-L-lysine copper) is a naturally occurring copper-binding tripeptide. Human plasma levels peak in early adulthood and decline with age. Pickart and colleagues (Pickart et al., 2015, Journal of Aging Research) documented its role in activating genes involved in tissue remodeling, collagen synthesis, and anti-inflammatory signaling. That foundational work is real and well-cited. However, those findings come largely from cell culture models and animal studies.
The half-life framing is biologically plausible. Small peptides like GHK-Cu are cleared rapidly through renal filtration and enzymatic degradation. But no published human pharmacokinetic study pinpoints "a few hours" for subcutaneous dosing specifically. The claim is reasonable but not directly supported by human data.
The 1.5 to 2 mg daily dose range has no clinical trial basis in humans. It circulates widely in peptide communities but originates from extrapolation and anecdote, not controlled research.
What did they get wrong (or right)?
Credit where it's due: the half-life logic is directionally correct. GHK-Cu is not a long-acting compound, and daily dosing to maintain activity is a reasonable inference from its pharmacology. The cycling recommendation, six to eight weeks on followed by a four-week break, also reflects common harm-reduction thinking in the peptide space, even if no clinical trial has tested that specific structure.
Where the video goes wrong is in the certainty. Saying daily dosing "maximizes skin quality and tissue repair benefits" implies a dose-response comparison that hasn't been done in humans. The creator presents a community-derived protocol as if it were established clinical guidance. It isn't.
The claim that alternating schedules produce "slower and less pronounced" results is presented as fact, but there is no human comparative data on dosing frequency for GHK-Cu. That statement is speculation dressed as evidence.
Skin-focused research on topical GHK-Cu (Finkley et al., 2007, Journal of Cosmetic Dermatology) shows measurable effects on skin density and collagen, but topical and injectable formulations behave differently, and the creator doesn't distinguish between them.
What should you actually know?
GHK-Cu has a legitimate and interesting research base, but most of it does not involve injectable human trials. Before anyone treats this video as a dosing guide, a few things matter.
First, injectable GHK-Cu is not FDA-approved, and compounded peptide formulations vary in quality, sterility, and actual concentration. The dose you think you're taking may not be the dose you're actually taking.
Second, copper peptides are not risk-free at elevated doses. Excess copper accumulation is a real concern, and nobody in the peptide content space talks about it enough. Long-term daily injectable use has not been studied for safety in humans.
Third, the six to eight week cycle structure is a reasonable precaution but not a clinically validated protocol. If you're working with a licensed provider through a regulated telehealth platform, they can help you evaluate whether this compound fits your health profile. If you're dosing based on TikTok alone, you're running an unmonitored experiment on yourself.
The enthusiasm around GHK-Cu is not baseless. The biology is genuinely interesting. But the gap between "interesting biology" and "here's exactly how to inject it daily" is wider than this video suggests.